Tirzepatide: The active ingredient in Mounjaro and Zepbound
Garzon S, Apostolopoulos V, Stojanovska L, Ferrari F, Mathyk BA, Lagana AS
Thus, this modest increase in LDL-C may be misleading regarding ASCVD risk, as patients with obesity may have a higher concentration of atherogenic small, dense LDL particles, and therefore high levels of apoB for a given blood LDL-C [10, 13]
I am neither for nor against this medication
TABLE 2 Immunomodulatory effects and mechanisms of bioactive metabolites of Zingiber and Alpinia species
These effects make it easier to reduce caloric intake, but nutrition plays a key role in supporting these outcomes